Patents by Inventor Michael Rolf Stegemann

Michael Rolf Stegemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosing regimen for Janus Kinase (JAK) inhibitors
    Patent number: 9522151
    Abstract: The present invention provides a method for treating allergic dermatitis, atopic dermatitis, or one or more symptoms thereof in a mammal in need, which method comprises administering to the mammal a first therapeutically effective dose of a Janus Kinase (JAK) inhibitor twice a day for a number of days sufficient to ease or eliminate one or more clinical signs in the mammal, followed by a second therapeutically effective dose of the JAK inhibitor at a reduced frequency.
    Type: Grant
    Filed: July 18, 2013
    Date of Patent: December 20, 2016
    Assignee: Zoetis Services LLC
    Inventors: Andrea J. Gonzales, Sallie B. Cosgrove, Phyllis B. Malpas, Michael Rolf Stegemann, Wendy Turner Collard
  • DOSING REGIMEN FOR JANUS KINASE (JAK) INHIBITORS
    Publication number: 20150126535
    Abstract: The present invention provides a method for treating allergic dermatitis, atopic dermatitis, or one or more symptoms thereof in a mammal in need, which method comprises administering to the mammal a first therapeutically effective dose of a Janus Kinase (JAK) inhibitor twice a day for a number of days sufficient to ease or eliminate one or more clinical signs in the mammal, followed by a second therapeutically effective dose of the JAK inhibitor at a reduced frequency.
    Type: Application
    Filed: July 18, 2013
    Publication date: May 7, 2015
    Inventors: Andrea J. Gonzales, Sallie B. Cosgrove, Phyllis B. Malpas, Michael Rolf Stegemann, Wendy Turner Collard